Advertisement
Drugs Made In America Acq... (DMAA)
NASDAQ: DMAA
· Real-Time Price · USD
10.08
0.00 (0.00%)
At close: Apr 29, 2025, 1:59 PM
10.09
0.10%
After-hours: Apr 29, 2025, 04:00 PM EDT
Company Description
Drugs Made In America Acquisition Corp. operates as a blank check company.
The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
Drugs Made In America Acquisition Corp. Ordinary Shares
| Country | United States |
| IPO Date | n/a |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Lynn Stockwell |
Advertisement
Contact Details
Address: 1 East Broward Blvd Suite 700 Fort Lauderdale, Florida United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | DMAA |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | n/a |
| CIK Code | 0002028614 |
| CUSIP Number | n/a |
| ISIN Number | n/a |
| Employer ID | 00-0000000 |
| SIC Code |
Key Executives
| Name | Position |
|---|---|
| Lynn Stockwell | Chief Executive Officer & Executive Chairman |
| Glenn Charles Worman | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 31, 2025 | 10-K | Annual Report |
| Mar 03, 2025 | SCHEDULE 13D | Filing |
| Feb 25, 2025 | 8-K | Current Report |
| Feb 24, 2025 | 8-K | Current Report |
| Feb 18, 2025 | 4 | Filing |
| Feb 18, 2025 | 4 | Filing |
| Feb 04, 2025 | 4 | Filing |
| Feb 04, 2025 | 4 | Filing |
| Feb 04, 2025 | 8-K | Current Report |
| Feb 03, 2025 | 4 | Filing |